0 0
Read Time:1 Minute, 41 Second

 

Doctors have lauded the government’s initiative to promote cervical cancer vaccination for girls aged 9 to 14, as announced in the Interim Budget presented by Union Finance Minister Nirmala Sitharaman. Cervical cancer, linked to the human papillomavirus (HPV), is the second leading cause of cancer death among Indian women. The vaccine has shown high efficacy rates in preventing cervical cancer, making it a crucial life-saving measure.

“I believe that it is a good call and a much-needed step considering the rising cases of cervical cases among youths in India,” stated Dr. Anuradha Vinod, Consultant in Paediatrics at Manipal Hospital, Bengaluru.

HPV vaccines, with a success rate of 88%, are administered in two doses before the age of 15 and three doses for those between 15 and 26. The vaccine is most effective when given to adolescents aged 9 to 14, helping in the primary prevention of cervical cancer.

Dr. Rama Joshi, Principal Director at Fortis Hospital, Gurugram, emphasized the significance of administering the vaccine before exposure to HPV. “The vaccine prevents the risk of HPV infection, the cause of cervical cancers,” she explained.

Cervical cancer is the second most common cancer in Indian women, accounting for 18% of all cancers in this demographic group. India represents 21% of global cervical cancer cases, causing 23% of deaths due to cancer in the country.

The Indian Academy of Paediatrics (IAP) recommends cervical cancer vaccines even for adolescent boys to prevent penile cancer risks later. Women aged 27 to 45 can also receive the HPV vaccine, but its effectiveness decreases with age.

Dr. Sunny Jain, Senior Consultant and HOD – Oncology at Marengo Asia Hospitals, Faridabad, expressed satisfaction with the government’s efforts towards cancer prevention and the inclusion of cervical cancer vaccination for girls aged 9 to 14.

While various HPV vaccines are available, their high prices pose a challenge. Doctors hope that the government’s program will provide subsidized rates, making the vaccine more accessible and helping reduce the burden of cervical cancer cases in India.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %